Kind Patches class action lawsuit overview:
- Who: Plaintiff Maria Alaimo filed a class action lawsuit against Kind Patches Limited.
- Why: Alaimo alleges the company falsely advertised its weight loss patches.
- Where: The Kind Patches class action was filed in New York federal court.
A new nationwide class action lawsuit alleges Kind Patches falsely advertises its GLP-1 patches as increasing natural GLP-1 levels comparable to actual GLP-1 agonist medications like Ozempic.
Plaintiff Maria Alaimo’s class action lawsuit alleges Kind Patches falsely claims that “750k People Are Obsessed with the GLP-1 Patches.”
GLP-1 is a hormone naturally produced by the human body that serves many functions, including slowing digestion, increasing the sensation of satiety after eating, telling the pancreas when to release insulin, and stopping glucose from entering the bloodstream, the Kind Patches class action explains.
Alaimo argues Kind Patches falsely claims its GLP-1 patches are a “Natural Version of Ozempic” that provide a “Stronger GLP-1 Boost” and “Support GLP-1 Production,” despite the fact that the patches do not contain a GLP-1 agonist.
Lawsuit: Kind Patches falsely claims GLP-1 patches ‘cost-effective alternative’
Alaimo alleges Kind Patches falsely claims its product contains “clinically proven ingredients that deliver real results.”
The company also falsely claims the GLP-1 patches are a “[a] smart, cost-effective alternative to expensive injections” that allow users to “skip the injections and discomfort” because “Kind Patches deliver active and all-natural ingredients through your skin—pain-free, mess-free, and easy to use anytime,” the Kind Patches class action alleges.
Alaimo seeks to represent a nationwide class of consumers who purchased Kind Patches’ GLP-1 patches and a New York subclass.
The Kind Patches class action lawsuit asserts claims for violations of New York General Business Law and unjust enrichment.
Alaimo demands a jury trial and requests declaratory and injunctive relief, compensatory damages and actual damages, trebled, exemplary and punitive damages, civil penalties, restitution and disgorgement, pre- and post-judgment interest, attorneys’ fees and costs, and expenses.
In related news, a federal judge in September largely denied a motion to dismiss a multi-district litigation (MDL) involving over 2,600 lawsuits regarding their GLP-1 weight-loss drugs like Ozempic and Wegovy.
If you were hospitalized due to side effects caused by Ozempic, Wegovy or Rybelsus, you may be eligible to pursue compensation.
What do you think of the allegations made in the Kind Patches class action lawsuit? Tell us your thoughts in the comments.
The plaintiff is represented by Raphael Janove of Janove PLLC and Ryan J. Ellersick of Zimmerman Reed LLP.
The Kind Patches class action lawsuit is Maria Alaimo v. Kind Patches Limited, Case No. 1:25-cv-06092, in the U.S. District Court for the Eastern District of New York.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
- Miracle-Gro class action claims organic soil and fertilizer products contain PFAS forever chemicals
- Candy Crush class action alleges lucrative All Stars tournament was unfair
- Jeni’s recalls ice cream bars over undeclared wheat and soy allergens
- DoorDash agrees to $18M settlement with Chicago over deceptive hidden fees
